← Open Payments lookup

KARINA ROLDAN: Open Payments

NPI 1619222742 · CARMICHAEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,389 in 102 payments from 24 companies in 2025. Trend: 2023 $2,615 · 2024 $2,692 · 2025 $2,389

Food & beverage: $2,389
CompanyPaymentsAmount
ABBVIE INC.35$509
Aimmune Therapeutics, Inc.11$428
Novo Nordisk Inc8$275
Neurocrine BioSciences, Inc.7$240
GlaxoSmithKline, LLC.9$181
Boehringer Ingelheim Pharmaceuticals, Inc.5$104
Ardelyx, Inc.3$78
Bayer Healthcare Pharmaceuticals Inc.2$65
AstraZeneca Pharmaceuticals LP1$64
Amgen Inc.3$57

Products named: ZENPEP, LINZESS, INGREZZA, Ozempic, TRELEGY ELLIPTA, CREON, JARDIANCE, IBSRELA.

Industry payments across CA — which companies pay providers there.